AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Coniglu M 2mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Coniak Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Coniglu M 2mg/1000mg Tablet SR

DiabetaComb 2mg/1000mg Extended-Release Tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication aids in regulating blood glucose levels. DiabetaComb should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Coniglu M 2mg/1000mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Coniglu M 2mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Coniglu M 2mg/1000mg SR tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Coniglu M 2mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Coniglu M 2mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Coniglu M 2mg/1000mg Tablet SR whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.

How Coniglu M 2mg/1000mg Tablet SR works:

Coniglu M SR tablets (2mg glimepiride/1000mg metformin) combine two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts triply: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Coniglu M 2mg/1000mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Coniglu M 2mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Coniglu M tablets (2mg/1000mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Coniglu M 2mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Coniglu M 2mg/1000mg SR tablets. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Coniglu M 2mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Coniglu M 2mg/1000mg Tablet SR :

Should you forget a Coniglu M 2mg/1000mg SR tablet, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Coniglu M 2mg/1000mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Treatment

FAQs on Coniglu M 2mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Coniglu M 2mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Coniglu M 2mg/1000mg Tablet SR and seek immediate medical attention.
Coniglu M 2mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Coniglu M 2mg/1000mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Coniglu M 2mg/1000mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Coniglu M 2mg/1000mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Coniglu M 2mg/1000mg Tablet SR with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Coniglu M 2mg/1000mg Tabl...
82
MRP 95
13% off